Found 11 matching trials
Study of Surzebiclimab (BGB-A425) and Alcestobart (LBL-007) in Combination With Tislelizumab in Advanced Solid Tumors PHASE1 This was an open-label, multicenter, nonrandomized Phase 1 and 2 clinical t...
Show More Location
Chao Family Comprehensive Cancer Center
Learn More & Join Trial
Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer PHASE2 This study was conducted to evaluate the preliminary effectiveness and safe...
Show More Location
The First Affiliated Hospital of Wannan Medical College
Learn More & Join Trial
Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies PHASE3 This is an open-label, multicenter, extension study to evaluate the long-te...
Show More Location
Mount Sinai Medical Center Braman Comprehensive Cancer Center
Learn More & Join Trial
A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors PHASE1 This trial is an open and multicenter phase Ib/II clinical study, which aim...
Show More Location
Anhui Cancer Hospital
Learn More & Join Trial
A Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer PHASE1 This is a Phase 1b/2 study to investigate the efficacy and safety of alcest...
Show More Status
Active Not Recruiting
Location
Alaska Oncology and Hematology, Llc
Learn More & Join Trial
A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma PHASE1 This study is an open-label, multicenter phase Ib/II study to evaluate the ...
Show More Location
Fujian Cancer Hospital
Learn More & Join Trial
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma PHASE2 This study is designed to evaluate the efficacy and safety of tislelizumab ...
Show More Status
Active Not Recruiting
Location
Valkyrie Clinical Trials
Learn More & Join Trial
A Study to Assess LBL-007 in Combination With Toripalimab and Axitinib Tablets Subjects With Advanced Melanoma PHASE1 A phase I clinical study evaluating LBL-007 in the treatment of subjects wi...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
A Phase Ib/II Clinical Study of LBL-007 in Combination With Toripalimab in Treatment of Advanced Malignant Tumors PHASE1 This is a single-arm, open-label, multicenter Phase Ib/II clinical study to...
Show More Location
The first affiliated hospital of bengbu medical University
Learn More & Join Trial
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer PHASE2 The purpose of this study is to assess the antitumor activity, safety, and ...
Show More Status
Active Not Recruiting
Location
Valkyrie Clinical Trials
Learn More & Join Trial